Found 243 matching trials
Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine PHASE1 Unresectable metastatic colorectal cancer (mCRC) remains an incurable disea...
Show More Status
Active Not Recruiting
Location
Centre Georges-François Leclerc
Learn More & Join Trial
TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer PHASE2 A randomized, controlled, open-label multicenter trial to assess the safety...
Show More Learn More & Join Trial
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping N/A Observational prospective cohort study designed to assess the mechanisms of...
Show More Location
St Bartholomews Hospital
Learn More & Join Trial
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer PHASE2 The study is to evaluate the R0 resection rate of patients with unresectabl...
Show More Location
Zhejiang procincial people's hospital
Learn More & Join Trial
Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines PHASE1 The primary purpose of this study is to prospectively determine whether cap...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer PHASE2 Although there have been remarkable advances in the treatment of metastatic...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer PHASE3 Background : In unresectable mCRC, a de-escalation strategy using maintenan...
Show More Learn More & Join Trial
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer PHASE3 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Mercy University Hospital
Learn More & Join Trial
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy PHASE3 Adult patients with gastric carcinoma which has progressed after initial tr...
Show More Location
Krankenhaus Nordwest
Learn More & Join Trial